Stock-based Compensation (Tables)
|
6 Months Ended |
Sep. 30, 2026 |
|---|
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of stock-based compensation expense [Table Text Block] |
| |
|
Three months ended September 30, |
|
|
Six months ended September 30, |
|
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Stock options |
$ |
3 |
|
$ |
29 |
|
$ |
12 |
|
$ |
64 |
|
| RSUs |
|
8,625 |
|
|
5,443 |
|
|
15,698 |
|
|
11,158 |
|
| Total |
$ |
8,628 |
|
$ |
5,472 |
|
$ |
15,710 |
|
$ |
11,222 |
|
|
| Schedule of changes in stock options outstanding [Table Text Block] |
| |
|
Outstanding |
|
|
Weighted average
exercise price - CAD
|
|
| |
|
|
|
|
|
|
| Balance, March 31, 2024 |
|
3,465,915 |
|
|
5.24 |
|
| Change in exercise price |
|
(1,605,015 |
) |
|
(3.32 |
) |
| |
|
|
|
|
|
|
| Balance, March 31, 2025 |
|
1,860,900 |
|
$ |
6.89 |
|
| Expired |
|
(2,000 |
) |
|
(15.70 |
) |
| Exercised |
|
(75,100 |
) |
|
(5.98 |
) |
| Balance, March 31, 2026 and September 30, 2026 |
|
1,783,800 |
|
$ |
6.93 |
|
| |
|
Outstanding |
|
|
Weighted average
exercise price - USD
|
|
| |
|
|
|
|
|
|
| Balance, March 31, 2025 |
|
1,450,400 |
|
$ |
2.53 |
|
| Exercised |
|
(600,000 |
) |
|
(1.21 |
) |
| Balance, March 31, 2026 and September 30,2026 |
|
850,400 |
|
$ |
3.47 |
|
|
| Schedule of stock options outstanding and exercisable [Table Text Block] |
| Outstanding |
|
Exercisable |
|
Exercise price - CAD |
|
Expiry date |
| |
|
|
|
|
|
|
| - |
|
- |
$ |
15.70 |
|
February 11. 2026 |
| 282,400 |
|
282,400 |
|
5.66 |
|
August 26, 2027 |
| 50,000 |
|
50,000 |
|
10.00 |
|
March 26, 2028 |
| 450,000 |
|
450,000 |
|
6.86 |
|
July 6, 2028 |
| 400,000 |
|
400,000 |
|
3.10 |
|
September 18, 2028 |
| 100,000 |
|
100,000 |
|
1.35 |
|
December 21, 2028 |
| 200,000 |
|
200,000 |
|
1.45 |
|
February 10, 2030 |
| 20,000 |
|
20,000 |
|
1.90 |
|
May 29, 2030 |
| 1,400 |
|
1,400 |
|
10.80 |
|
December 24, 2030 |
| 60,000 |
|
60,000 |
|
18.35 |
|
April 29, 2031 |
| 180,000 |
|
180,000 |
|
18.50 |
|
October 7, 2031 |
| 40,000 |
|
40,000 |
|
25.35 |
|
November 10, 2031 |
| 1,783,800 |
|
1,783,800 |
|
|
|
|
| Outstanding |
|
Exercisable |
|
Exercise price -
USD |
|
Expiry date |
| |
|
|
|
|
|
|
| 50,400 |
|
50,400 |
$ |
4.36 |
|
August 26, 2027 |
| 500,000 |
|
500,000 |
|
1.23 |
|
September 14, 2027 |
| 130,000 |
|
130,000 |
|
5.14 |
|
July 6, 2028 |
| 100,000 |
|
100,000 |
|
1.09 |
|
February 10, 2030 |
| 30,000 |
|
30,000 |
|
20.03 |
|
April 6, 2031 |
| 20,000 |
|
- |
|
20.36 |
|
November 10, 2031 |
| 20,000 |
|
20,000 |
|
16.61 |
|
December 9, 2031 |
| 850,400 |
|
830,400 |
|
|
|
|
|
| Schedule of changes in restricted share units outstanding [Table Text Block] |
| |
|
Outstanding |
|
| |
|
|
|
| Balance, March 31, 2024 |
$ |
1,379,056 |
|
| Granted |
|
6,050,000 |
|
| Exercised |
|
(326,644 |
) |
| Balance, March 31, 2025 |
$ |
7,102,412 |
|
| |
|
|
|
| Granted |
|
11,176,300 |
|
| Exercised |
|
(3,125,950 |
) |
| Balance, March 31, 2026 |
$ |
15,152,762 |
|
| |
|
|
|
| Granted |
|
3,641,800 |
|
| Exercised |
|
(3,177,875 |
) |
| Balance, September 30, 2026 |
$ |
15,616,687 |
|
|